• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低级别蛛网膜下腔出血的重症监护管理

The critical care management of poor-grade subarachnoid haemorrhage.

作者信息

de Oliveira Manoel Airton Leonardo, Goffi Alberto, Marotta Tom R, Schweizer Tom A, Abrahamson Simon, Macdonald R Loch

机构信息

St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B 1 W8, Canada.

Keenan Research Centre for Biomedical Science of St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B 1 W8, Canada.

出版信息

Crit Care. 2016 Jan 23;20:21. doi: 10.1186/s13054-016-1193-9.

DOI:10.1186/s13054-016-1193-9
PMID:26801901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4724088/
Abstract

Aneurysmal subarachnoid haemorrhage is a neurological syndrome with complex systemic complications. The rupture of an intracranial aneurysm leads to the acute extravasation of arterial blood under high pressure into the subarachnoid space and often into the brain parenchyma and ventricles. The haemorrhage triggers a cascade of complex events, which ultimately can result in early brain injury, delayed cerebral ischaemia, and systemic complications. Although patients with poor-grade subarachnoid haemorrhage (World Federation of Neurosurgical Societies 4 and 5) are at higher risk of early brain injury, delayed cerebral ischaemia, and systemic complications, the early and aggressive treatment of this patient population has decreased overall mortality from more than 50% to 35% in the last four decades. These management strategies include (1) transfer to a high-volume centre, (2) neurological and systemic support in a dedicated neurological intensive care unit, (3) early aneurysm repair, (4) use of multimodal neuromonitoring, (5) control of intracranial pressure and the optimisation of cerebral oxygen delivery, (6) prevention and treatment of medical complications, and (7) prevention, monitoring, and aggressive treatment of delayed cerebral ischaemia. The aim of this article is to provide a summary of critical care management strategies applied to the subarachnoid haemorrhage population, especially for patients in poor neurological condition, on the basis of the modern concepts of early brain injury and delayed cerebral ischaemia.

摘要

动脉瘤性蛛网膜下腔出血是一种伴有复杂全身并发症的神经综合征。颅内动脉瘤破裂导致动脉血在高压下急性外渗至蛛网膜下腔,且常进入脑实质和脑室。出血引发一系列复杂事件,最终可导致早期脑损伤、迟发性脑缺血和全身并发症。尽管低分级蛛网膜下腔出血患者(世界神经外科协会联盟分级4级和5级)发生早期脑损伤、迟发性脑缺血和全身并发症的风险较高,但在过去四十年中,对这一患者群体的早期积极治疗已使总体死亡率从超过50%降至35%。这些管理策略包括:(1)转至大容量中心;(2)在专门的神经重症监护病房进行神经和全身支持;(3)早期动脉瘤修复;(4)使用多模式神经监测;(5)控制颅内压并优化脑氧输送;(6)预防和治疗医疗并发症;(7)预防、监测和积极治疗迟发性脑缺血。本文旨在基于早期脑损伤和迟发性脑缺血的现代概念,总结应用于蛛网膜下腔出血患者群体,尤其是神经状况较差患者的重症监护管理策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b116/4724088/97e864a64356/13054_2016_1193_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b116/4724088/7d8834ef992b/13054_2016_1193_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b116/4724088/890fe5cdf812/13054_2016_1193_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b116/4724088/6e0edf794b9a/13054_2016_1193_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b116/4724088/97e864a64356/13054_2016_1193_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b116/4724088/7d8834ef992b/13054_2016_1193_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b116/4724088/890fe5cdf812/13054_2016_1193_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b116/4724088/6e0edf794b9a/13054_2016_1193_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b116/4724088/97e864a64356/13054_2016_1193_Fig4_HTML.jpg

相似文献

1
The critical care management of poor-grade subarachnoid haemorrhage.低级别蛛网膜下腔出血的重症监护管理
Crit Care. 2016 Jan 23;20:21. doi: 10.1186/s13054-016-1193-9.
2
Critical care of poor-grade subarachnoid hemorrhage.严重程度分级差的蛛网膜下腔出血的重症监护。
Curr Opin Crit Care. 2011 Apr;17(2):85-93. doi: 10.1097/MCC.0b013e328342f83d.
3
Cerebral Autoregulation in the Prediction of Delayed Cerebral Ischemia and Clinical Outcome in Poor-Grade Aneurysmal Subarachnoid Hemorrhage Patients.脑自动调节在预测差分级动脉瘤性蛛网膜下腔出血患者迟发性脑缺血和临床结局中的作用。
Crit Care Med. 2018 May;46(5):774-780. doi: 10.1097/CCM.0000000000003016.
4
Prevention and treatment of medical and neurological complications in patients with aneurysmal subarachnoid haemorrhage.动脉瘤性蛛网膜下腔出血患者医学及神经并发症的防治
Pract Neurol. 2009 Aug;9(4):195-209. doi: 10.1136/jnnp.2009.182444.
5
Intensive care management of patients with subarachnoid haemorrhage.蛛网膜下腔出血患者的重症监护管理
Curr Opin Anaesthesiol. 2007 Oct;20(5):400-7. doi: 10.1097/ACO.0b013e3282efa686.
6
Management of patients with aneurysmal subarachnoid haemorrhage.动脉瘤性蛛网膜下腔出血患者的管理
Curr Opin Neurol. 2016 Feb;29(1):37-41. doi: 10.1097/WCO.0000000000000282.
7
Delayed cerebral ischaemia prevention and treatment after aneurysmal subarachnoid haemorrhage: a systematic review.颅内动脉瘤性蛛网膜下腔出血后迟发性脑缺血的预防和治疗:系统评价。
Br J Anaesth. 2016 Jul;117(1):17-40. doi: 10.1093/bja/aew095. Epub 2016 May 8.
8
Management of aneurysmal subarachnoid haemorrhage.颅内动脉瘤性蛛网膜下腔出血的处理。
Swiss Med Wkly. 2014 Apr 29;144:w13934. doi: 10.4414/smw.2014.13934. eCollection 2014.
9
HIMALAIA (Hypertension Induction in the Management of AneurysmaL subArachnoid haemorrhage with secondary IschaemiA): a randomized single-blind controlled trial of induced hypertension vs. no induced hypertension in the treatment of delayed cerebral ischemia after subarachnoid hemorrhage.希马拉雅(蛛网膜下腔出血继发缺血性脑动脉瘤治疗中的高血压诱导):一项关于蛛网膜下腔出血后迟发性脑缺血治疗中诱导高血压与非诱导高血压的随机单盲对照试验。
Int J Stroke. 2014 Apr;9(3):375-80. doi: 10.1111/ijs.12055. Epub 2013 May 22.
10
Emergency Medical Management of Aneurysmal Subarachnoid Hemorrhage.颅内动脉瘤性蛛网膜下腔出血的急诊处理。
Neurocrit Care. 2023 Aug;39(1):51-58. doi: 10.1007/s12028-023-01757-7. Epub 2023 Jun 21.

引用本文的文献

1
Glibenclamide in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.格列本脲在动脉瘤性蛛网膜下腔出血中的应用:随机对照试验的系统评价和荟萃分析
Cureus. 2025 Aug 14;17(8):e90067. doi: 10.7759/cureus.90067. eCollection 2025 Aug.
2
Delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a narrative review.动脉瘤性蛛网膜下腔出血后的迟发性脑缺血:一项叙述性综述
Arq Neuropsiquiatr. 2025 Jun;83(6):1-14. doi: 10.1055/s-0045-1809885. Epub 2025 Jun 25.
3
Evidence-Based Approach to Cerebral Vasospasm and Delayed Cerebral Ischemia: Milrinone as a Therapeutic Option-A Narrative Literature Review and Algorithm Treatment Proposition.

本文引用的文献

1
The VASOGRADE: A Simple Grading Scale for Prediction of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage.VASOGRADE:一种用于预测蛛网膜下腔出血后迟发性脑缺血的简单分级量表。
Stroke. 2015 Jul;46(7):1826-31. doi: 10.1161/STROKEAHA.115.008728. Epub 2015 May 14.
2
Managing aneurysmal subarachnoid hemorrhage: It takes a team.管理动脉瘤性蛛网膜下腔出血:这需要一个团队。
Cleve Clin J Med. 2015 Mar;82(3):177-92. doi: 10.3949/ccjm.82a.14021.
3
Early brain injury after aneurysmal subarachnoid hemorrhage: a multimodal neuromonitoring study.
基于证据的脑血管痉挛和迟发性脑缺血治疗方法:米力农作为一种治疗选择——叙述性文献综述及治疗算法建议
Neurol Int. 2025 Feb 21;17(3):32. doi: 10.3390/neurolint17030032.
4
Investigation of neuroprotective effects of H by CiteSpace-based bibliometric analysis.基于CiteSpace的文献计量分析对H的神经保护作用的研究。
Brain Circ. 2024 Sep 26;10(3):229-239. doi: 10.4103/bc.bc_111_23. eCollection 2024 Jul-Sep.
5
CT perfusion-guided administration of IV milrinone is associated with a reduction in delayed cerebral infarction after subarachnoid hemorrhage.CT 灌注引导下静脉注射米力农与蛛网膜下腔出血后迟发性脑梗死的减少有关。
Sci Rep. 2024 Jun 27;14(1):14856. doi: 10.1038/s41598-024-65706-w.
6
A Mediation Analysis of the Association Between Systemic Inflammation Response Index, in-Hospital Complications, and Poor Long-Term Functional Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage: Insights from a Large Prospective Cohort Study.动脉瘤性蛛网膜下腔出血患者全身炎症反应指数、院内并发症与长期功能预后不良之间关联的中介分析:来自大型前瞻性队列研究的见解
J Inflamm Res. 2024 Jun 10;17:3697-3708. doi: 10.2147/JIR.S460364. eCollection 2024.
7
Serum C-reactive protein value on day 14 as a possible prognostic factor of aneurysmal subarachnoid hemorrhage.第 14 天血清 C 反应蛋白值作为动脉瘤性蛛网膜下腔出血的可能预后因素。
J Int Med Res. 2024 May;52(5):3000605241253755. doi: 10.1177/03000605241253755.
8
The Role of Nursing Care in the Management of Patients with Traumatic Subarachnoid Hemorrhage.护理在创伤性蛛网膜下腔出血患者管理中的作用
Galen Med J. 2023 Aug 20;12:e3013. doi: 10.31661/gmj.v12i0.3013. eCollection 2023.
9
Evaluation of CSF 8-iso-prostaglandin F2α and erythrocyte anisocytosis as prognostic biomarkers for delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.评估 CSF 8-异前列腺素 F2α 和红细胞不均一性作为动脉瘤性蛛网膜下腔出血后迟发性脑缺血的预后生物标志物。
Sci Rep. 2024 May 17;14(1):11302. doi: 10.1038/s41598-024-61956-w.
10
Clinical Outcome of Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage with Bundled Treatments: A Propensity Score-Matched Analysis.采用捆绑式治疗的低级别动脉瘤性蛛网膜下腔出血患者的临床结局:一项倾向评分匹配分析。
Neurocrit Care. 2024 Feb;40(1):177-186. doi: 10.1007/s12028-023-01818-x. Epub 2023 Aug 23.
动脉瘤性蛛网膜下腔出血后的早期脑损伤:一项多模态神经监测研究
Crit Care. 2015 Mar 9;19(1):75. doi: 10.1186/s13054-015-0809-9.
4
Hemostasis and fibrinolysis in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review.动脉瘤性蛛网膜下腔出血后迟发性脑缺血中的止血与纤溶:一项系统评价
J Cereb Blood Flow Metab. 2015 May;35(5):724-33. doi: 10.1038/jcbfm.2015.13. Epub 2015 Feb 18.
5
Haptoglobin phenotype predicts the development of focal and global cerebral vasospasm and may influence outcomes after aneurysmal subarachnoid hemorrhage.触珠蛋白表型可预测局灶性和全身性脑血管痉挛的发生,并可能影响动脉瘤性蛛网膜下腔出血后的预后。
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1155-60. doi: 10.1073/pnas.1412833112. Epub 2015 Jan 12.
6
High-dose simvastatin for aneurysmal subarachnoid hemorrhage: multicenter randomized controlled double-blinded clinical trial.大剂量辛伐他汀用于动脉瘤性蛛网膜下腔出血:多中心随机对照双盲临床试验。
Stroke. 2015 Feb;46(2):382-8. doi: 10.1161/STROKEAHA.114.007006. Epub 2014 Dec 16.
7
The durability of endovascular coiling versus neurosurgical clipping of ruptured cerebral aneurysms: 18 year follow-up of the UK cohort of the International Subarachnoid Aneurysm Trial (ISAT).破裂性脑动脉瘤血管内栓塞与神经外科夹闭术的耐久性:国际蛛网膜下腔动脉瘤试验(ISAT)英国队列的18年随访
Lancet. 2015 Feb 21;385(9969):691-7. doi: 10.1016/S0140-6736(14)60975-2. Epub 2014 Oct 28.
8
Safety of early pharmacological thromboprophylaxis after subarachnoid hemorrhage.蛛网膜下腔出血后早期药物性血栓预防的安全性
Can J Neurol Sci. 2014 Sep;41(5):554-61. doi: 10.1017/cjn.2014.16.
9
Intracranial pressure after subarachnoid hemorrhage.蛛网膜下腔出血后的颅内压
Crit Care Med. 2015 Jan;43(1):168-76. doi: 10.1097/CCM.0000000000000670.
10
The role of neuromuscular blockade in patients with traumatic brain injury: a systematic review.神经肌肉阻滞在创伤性脑损伤患者中的作用:一项系统综述。
Neurocrit Care. 2015 Apr;22(2):325-34. doi: 10.1007/s12028-014-0061-1.